Oxford BioMedica PLC (OXB) — Long-term Investment Intensity

Latest as of December 2018: 9.8%

Oxford BioMedica PLC (OXB) has a Long-term Investment Intensity of 9.8% as of December 2018. Long-term investments of GBX10.97 Million represent 9.8% of total assets of GBX112.40 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See OXB net assets for net asset value and shareholders' equity analysis.

LT Investment Intensity

9.8%
LT Investments / Total Assets

Long-term Investments

GBX10.97 Million
GBX

Total Assets

GBX112.40 Million
GBX

Country

UK
LSE

Oxford BioMedica PLC Long-term Investment Intensity (2016–2018)

This chart shows how Oxford BioMedica PLC's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of December 2018, the intensity stands at 9.8%, reflecting long-term investments of GBX10.97 Million against total assets of GBX112.40 Million GBX. Also explore OXB total assets for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Oxford BioMedica PLC (2016–2018)

The table below presents the year-by-year Long-term Investment Intensity for Oxford BioMedica PLC from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see OXB company net worth.

Year LT Investment Intensity LT Investments (GBX) Total Assets Change (pp)
2018 9.8% GBX10.97 Million GBX112.40 Million ▲ +5.2 pp
2017 4.5% GBX2.95 Million GBX65.40 Million ▲ +3.4 pp
2016 1.2% GBX657.00K GBX56.94 Million
pp = percentage points